X

Trial Profile

A Phase-1b Dose Escalation Study to Assess the Effect of NG11-2 on Radiation Induced Oral Mucositis in Patients With Head & Neck Cancer

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 08 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs NG11-2 (Primary)
Indications Mucositis; Radiation-induced abnormalities
Focus Adverse reactions
Sponsors VasoDynamics

Most Recent Events

08 Nov 2024 New trial record
20 Oct 2024 According to a VasoDynamics media release, has today received the official approval from UK HRA/MHRA for their Phase-1b clinical trial application.
09 May 2024 According to a VasoDynamics media release, full study results are expected in early Q4 of 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com